STOCK TITAN

Freenome, Inc. (PCSC) director reports common stock and option stakes

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Deepika Pakianathan, a director of Freenome, Inc., reports beneficial ownership of 13,918 shares of Common Stock held directly, plus several stock option awards over additional Common Stock. These options cover 14,144, 6,365, 3,359, 7,359, 9,588 and 6,484 underlying shares with exercise prices between $8.45 and $18.24, expiring from 2031 through 2035. Some options are fully vested, while others vest in 48 equal monthly installments starting June 28, 2023 or March 2, 2024, and certain options may have their exercise price automatically reduced to $8.45 upon specified events.

Positive

  • None.

Negative

  • None.
Insider PAKIANATHAN DEEPIKA
Role Director
Type Security Shares Price Value
holding Stock Option (right to buy) F4, F1 -- -- --
holding Stock Option (right to buy) F4, F1 -- -- --
holding Stock Option (right to buy) F4, F2 -- -- --
holding Stock Option (right to buy) F4, F3 -- -- --
holding Stock Option (right to buy) F4, F1 -- -- --
holding Stock Option (right to buy) F1 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (right to buy) — 47,299 shares (Direct); Common Stock — 13,918 shares (Direct)
Footnotes (4)
  1. F1. The shares subject to this option are fully vested.
  2. F2. The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments commencing from June 28, 2023, subject to the Reporting Person's continued service on each such vesting date.
  3. F3. The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments commencing from March 2, 2024, subject to the Reporting Person's continued service on each such vesting date.
  4. F4. This option was previously amended, pursuant to which the exercise price of the option will be automatically reduced to $8.45 upon the occurrence of certain events.
Direct Common Stock 13,918 shares Common Stock held directly by the reporting person as of 2026-07-20
Option underlying shares (2031-12-20) 14,144 shares Common Stock underlying a stock option at $15.9100 expiring 2031-12-20
Option underlying shares (2032-06-27) 6,365 shares Common Stock underlying a stock option at $15.9100 expiring 2032-06-27
Option underlying shares (2033-09-10) 3,359 shares Common Stock underlying a stock option at $14.9200 expiring 2033-09-10
Option underlying shares (2034-03-01) 7,359 shares Common Stock underlying a stock option at $18.2400 expiring 2034-03-01
Option underlying shares (2035-05-28) 9,588 shares Common Stock underlying a stock option at $14.0000 expiring 2035-05-28
Option underlying shares (2035-10-23) 6,484 shares Common Stock underlying a stock option at $8.4500 expiring 2035-10-23
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"the exercise price of the option will be automatically reduced to $8.45"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"shall vest and become exercisable in forty-eight (48) equal monthly installments"
Power of Attorney regulatory
"Remarks: Exhibit 24 - Power of Attorney"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider holdings does the Form 3 for PCSC and Freenome, Inc. show?

The Form 3 reports that director Deepika Pakianathan holds 13,918 shares of Freenome Common Stock directly, plus multiple stock option awards. These options provide rights to acquire additional Common Stock at exercise prices ranging from $8.45 to $18.24, with expirations from 2031 to 2035.

How many Freenome, Inc. common shares does Deepika Pakianathan directly own in this PCSC-related filing?

Deepika Pakianathan directly owns 13,918 shares of Freenome Common Stock. This direct ownership is reported as a holding, not as a new purchase or sale, and reflects her beneficial stake separate from additional shares underlying stock options.

What stock option awards are reported for Deepika Pakianathan in the Freenome (PCSC) disclosure?

She holds several stock options over Common Stock with exercise prices of $15.91, $14.92, $18.24, $14.00 and $8.45. These options cover tranches of 14,144, 6,365, 3,359, 7,359, 9,588 and 6,484 underlying shares, expiring between 2031 and 2035.

How do the vesting schedules work for the options reported in the Freenome, Inc. Form 3 tied to PCSC?

Some options are fully vested, while others vest in 48 equal monthly installments. One grant vests from June 28, 2023, and another from March 2, 2024, each subject to Pakianathan’s continued service on each monthly vesting date.

Is there any special pricing feature on Deepika Pakianathan’s Freenome stock options in this PCSC context?

Yes. A reported amendment states that for certain options the exercise price will be automatically reduced to $8.45 upon the occurrence of specified events. Until such events occur, the options carry higher exercise prices such as $15.91, $14.92, $18.24 or $14.00.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
PAKIANATHAN DEEPIKA

(Last)(First)(Middle)
C/O FREENOME, INC.
51 ASTOR PLACE, 10TH FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
07/20/2026
3. Issuer Name and Ticker or Trading Symbol
Freenome, Inc. [ FRNM ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock13,918D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) (1)12/20/2031Common Stock14,144$15.91(4)D
Stock Option (right to buy) (1)06/27/2032Common Stock6,365$15.91(4)D
Stock Option (right to buy) (2)09/10/2033Common Stock3,359$14.92(4)D
Stock Option (right to buy) (3)03/01/2034Common Stock7,359$18.24(4)D
Stock Option (right to buy) (1)05/28/2035Common Stock9,588$14(4)D
Stock Option (right to buy) (1)10/23/2035Common Stock6,484$8.45D
Explanation of Responses:
1. The shares subject to this option are fully vested.
2. The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments commencing from June 28, 2023, subject to the Reporting Person's continued service on each such vesting date.
3. The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments commencing from March 2, 2024, subject to the Reporting Person's continued service on each such vesting date.
4. This option was previously amended, pursuant to which the exercise price of the option will be automatically reduced to $8.45 upon the occurrence of certain events.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Thomas Fitzpatrick, Attorney-in-Fact07/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)